USD 1.39
(-7.95%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | 100.0% |
2022 | -103 Thousand USD | 40.8% |
2021 | -174 Thousand USD | -3380.0% |
2020 | -5000.00 USD | 99.81% |
2019 | -2.62 Million USD | 0.0% |
2018 | - USD | -100.0% |
2017 | 73 Thousand USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 2.36 Million USD | 670.12% |
2014 | -415.63 Thousand USD | 30.15% |
2013 | -595.03 Thousand USD | -210.69% |
2012 | 537.59 Thousand USD | 300.57% |
2011 | -268.02 Thousand USD | -143.87% |
2010 | 610.98 Thousand USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
1996 | - USD | 0.0% |
1995 | - USD | 0.0% |
1994 | - USD | 0.0% |
1993 | - USD | 0.0% |
1992 | - USD | 0.0% |
1991 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 100.0% |
2023 FY | - USD | 100.0% |
2023 Q3 | - USD | 0.0% |
2022 Q4 | -103 Thousand USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 FY | -103 Thousand USD | 40.8% |
2022 Q3 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q1 | - USD | 100.0% |
2021 FY | -174 Thousand USD | -3380.0% |
2021 Q4 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2020 FY | -5000.00 USD | 99.81% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | -5000.00 USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | -2.62 Million USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | - USD | -100.0% |
2018 Q1 | - USD | -100.0% |
2018 Q2 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2017 Q4 | 73 Thousand USD | 15566.1% |
2017 Q3 | -472.00 USD | 13.39% |
2017 Q2 | -545.00 USD | 0.0% |
2017 FY | 73 Thousand USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 FY | - USD | -100.0% |
2016 Q1 | - USD | -100.0% |
2016 Q2 | 2.3 Million USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | -100.0% |
2015 FY | 2.36 Million USD | 670.12% |
2015 Q1 | 985.71 Thousand USD | 337.16% |
2015 Q2 | 883.06 Thousand USD | -10.41% |
2015 Q3 | 921.95 Thousand USD | 4.4% |
2015 Q4 | 2.36 Million USD | 157.02% |
2014 Q2 | 724.67 Thousand USD | 59.65% |
2014 Q4 | -415.63 Thousand USD | -70.09% |
2014 Q1 | 453.91 Thousand USD | 176.28% |
2014 FY | -415.63 Thousand USD | 30.15% |
2014 Q3 | -244.36 Thousand USD | -133.72% |
2013 Q3 | 516.27 Thousand USD | -17.39% |
2013 Q4 | -595.03 Thousand USD | -215.26% |
2013 FY | -595.03 Thousand USD | -210.69% |
2013 Q1 | 434 Thousand USD | -19.27% |
2013 Q2 | 624.93 Thousand USD | 43.99% |
2012 Q2 | -312.01 Thousand USD | -183.61% |
2012 Q3 | 388.29 Thousand USD | 224.45% |
2012 Q4 | 537.59 Thousand USD | 38.45% |
2012 FY | 537.59 Thousand USD | 300.57% |
2012 Q1 | 373.17 Thousand USD | -26.32% |
2011 Q3 | -604.18 Thousand USD | -17.15% |
2011 Q1 | -307.58 Thousand USD | -150.34% |
2011 Q4 | 506.46 Thousand USD | 183.83% |
2011 FY | -268.02 Thousand USD | -143.87% |
2011 Q2 | -515.73 Thousand USD | -67.67% |
2010 Q1 | - USD | 0.0% |
2010 FY | 610.98 Thousand USD | 0.0% |
2010 Q4 | 610.98 Thousand USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2001 Q3 | - USD | -100.0% |
2001 Q4 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q1 | 909.41 Thousand USD | 0.0% |
2001 Q2 | 376.68 Thousand USD | -58.58% |
2000 Q1 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1998 Q1 | - USD | 0.0% |
1998 FY | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1997 FY | - USD | 0.0% |
1997 Q2 | - USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1997 Q4 | - USD | 0.0% |
1997 Q1 | - USD | 0.0% |
1996 FY | - USD | 0.0% |
1996 Q4 | - USD | 0.0% |
1996 Q3 | - USD | 0.0% |
1996 Q1 | - USD | 0.0% |
1996 Q2 | - USD | 0.0% |
1995 Q2 | - USD | 0.0% |
1995 FY | - USD | 0.0% |
1995 Q4 | - USD | 0.0% |
1995 Q3 | - USD | 0.0% |
1995 Q1 | - USD | 0.0% |
1994 Q1 | - USD | 0.0% |
1994 Q4 | - USD | 0.0% |
1994 Q3 | - USD | 0.0% |
1994 Q2 | - USD | 0.0% |
1994 FY | - USD | 0.0% |
1993 Q2 | - USD | 0.0% |
1993 Q4 | - USD | 0.0% |
1993 FY | - USD | 0.0% |
1993 Q1 | - USD | 0.0% |
1992 Q4 | - USD | 0.0% |
1992 FY | - USD | 0.0% |
1991 Q4 | - USD | 0.0% |
1991 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Akoya Biosciences, Inc. | 17.87 Million USD | 100.0% |
AngioDynamics, Inc. | 60.61 Million USD | 100.0% |
AtriCure, Inc. | 67.89 Million USD | 100.0% |
Avinger, Inc. | 5.29 Million USD | 100.0% |
Azenta, Inc. | 128.19 Million USD | 100.0% |
BioLife Solutions, Inc. | 43.45 Million USD | 100.0% |
The Cooper Companies, Inc. | 735.6 Million USD | 100.0% |
Daxor Corporation | - USD | NaN% |
Ekso Bionics Holdings, Inc. | 5.05 Million USD | 100.0% |
Femasys Inc. | 667.11 Thousand USD | 100.0% |
GlucoTrack, Inc. | - USD | NaN% |
Harvard Bioscience, Inc. | 24.71 Million USD | 100.0% |
Hologic, Inc. | 679.8 Million USD | 100.0% |
ICU Medical, Inc. | 709.36 Million USD | 100.0% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 100.0% |
KORU Medical Systems, Inc. | 3.48 Million USD | 100.0% |
LeMaitre Vascular, Inc. | 52.33 Million USD | 100.0% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | 100.0% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | 100.0% |
Masimo Corporation | 545 Million USD | 100.0% |
Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | 100.0% |
Merit Medical Systems, Inc. | 303.87 Million USD | 100.0% |
Nephros, Inc. | 2.47 Million USD | 100.0% |
NovoCure Limited | 38.15 Million USD | 100.0% |
NEXGEL, Inc. | 1.31 Million USD | 100.0% |
NEXGEL, Inc. | 1.31 Million USD | 100.0% |
Singular Genomics Systems, Inc. | 13.57 Million USD | 100.0% |
OraSure Technologies, Inc. | 47.61 Million USD | 100.0% |
Pro-Dex, Inc. | 15.26 Million USD | 100.0% |
Pulse Biosciences, Inc. | - USD | NaN% |
Predictive Oncology Inc. | 494.37 Thousand USD | 100.0% |
Precision Optics Corporation, Inc. | 2.86 Million USD | 100.0% |
QuidelOrtho Corporation | 577.8 Million USD | 100.0% |
Repligen Corporation | 202.32 Million USD | 100.0% |
Sanara MedTech Inc. | 4.71 Million USD | 100.0% |
STAAR Surgical Company | 35.13 Million USD | 100.0% |
Sharps Technology, Inc. | 1.7 Million USD | 100.0% |
Utah Medical Products, Inc. | 9.58 Million USD | 100.0% |
DENTSPLY SIRONA Inc. | 624 Million USD | 100.0% |
Jin Medical International Ltd. | 5.05 Million USD | 100.0% |